Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.
Kinloch-de Loes S, Hoen B, Smith DE, Autran B, Lampe FC, Phillips AN, Goh LE, Andersson J, Tsoukas C, Sonnerborg A, Tambussi G, Girard PM, Bloch M, Battegay M, Carter N, El Habib R, Theofan G, Cooper DA, Perrin L; QUEST Study Group. Kinloch-de Loes S, et al. Among authors: sonnerborg a. J Infect Dis. 2005 Aug 15;192(4):607-17. doi: 10.1086/432002. Epub 2005 Jul 15. J Infect Dis. 2005. PMID: 16028129 Clinical Trial.
Antiretroviral treatment of HIV infection: Swedish recommendations 2007.
Josephson F, Albert J, Flamholc L, Gisslén M, Karlström O, Lindgren SR, Navér L, Sandström E, Svedhem-Johansson V, Svennerholm B, Sönnerborg A. Josephson F, et al. Among authors: sonnerborg a. Scand J Infect Dis. 2007;39(6-7):486-507. doi: 10.1080/00365540701383154. Scand J Infect Dis. 2007. PMID: 17577810 Review.
Selecting anti-HIV therapies based on a variety of genomic and clinical factors.
Rosen-Zvi M, Altmann A, Prosperi M, Aharoni E, Neuvirth H, Sönnerborg A, Schülter E, Struck D, Peres Y, Incardona F, Kaiser R, Zazzi M, Lengauer T. Rosen-Zvi M, et al. Among authors: sonnerborg a. Bioinformatics. 2008 Jul 1;24(13):i399-406. doi: 10.1093/bioinformatics/btn141. Bioinformatics. 2008. PMID: 18586740 Free PMC article.
Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy.
Altmann A, Rosen-Zvi M, Prosperi M, Aharoni E, Neuvirth H, Schülter E, Büch J, Struck D, Peres Y, Incardona F, Sönnerborg A, Kaiser R, Zazzi M, Lengauer T. Altmann A, et al. Among authors: sonnerborg a. PLoS One. 2008;3(10):e3470. doi: 10.1371/journal.pone.0003470. Epub 2008 Oct 21. PLoS One. 2008. PMID: 18941628 Free PMC article.
Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
Altmann A, Sing T, Vermeiren H, Winters B, Van Craenenbroeck E, Van der Borght K, Rhee SY, Shafer RW, Schülter E, Kaiser R, Peres Y, Sönnerborg A, Fessel WJ, Incardona F, Zazzi M, Bacheler L, Van Vlijmen H, Lengauer T. Altmann A, et al. Among authors: sonnerborg a. Antivir Ther. 2009;14(2):273-83. Antivir Ther. 2009. PMID: 19430102
Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
Prosperi MC, Altmann A, Rosen-Zvi M, Aharoni E, Borgulya G, Bazso F, Sönnerborg A, Schülter E, Struck D, Ulivi G, Vandamme AM, Vercauteren J, Zazzi M; EuResist and Virolab study groups. Prosperi MC, et al. Among authors: sonnerborg a. Antivir Ther. 2009;14(3):433-42. Antivir Ther. 2009. PMID: 19474477
Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.
Prosperi MC, Rosen-Zvi M, Altmann A, Zazzi M, Di Giambenedetto S, Kaiser R, Schülter E, Struck D, Sloot P, van de Vijver DA, Vandamme AM, Sönnerborg A; EuResist study group; Virolab study group. Prosperi MC, et al. Among authors: sonnerborg a. PLoS One. 2010 Oct 29;5(10):e13753. doi: 10.1371/journal.pone.0013753. PLoS One. 2010. PMID: 21060792 Free PMC article.
506 results